Providers/Grant Support
Provided by Kaplan Medical Education in partnership with the American Academy of Physical Medicine and Rehabilitation and the Howard University College of Pharmacy.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Credits Available
- Physicians — maximum of 6.00 AMA PRA Category 1 Credits™
- Nurses — 6.00 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Completion of all 6 POWER Modules is required for REMS compliance.
Target Audience
The target audience for this activity includes obstetricians/gynecologists, primary care physicians, physical medicine and rehabilitation physicians, emergency medicine physicians, pain management physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals contributing to the interdisciplinary care team.
Program Overview
The goal of this activity is to equip interprofessional clinicians with practical strategies regarding opioid risks and to evaluate appropriate pain management approaches, including nonopioid options. Emphasis is placed on culturally competent strategies for women of diverse racial and ethnic backgrounds.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Identify at least three implicit biases that can impact the assessment and treatment of pain in women.
- Explain the biological and social factors that influence pain perception and expression in women, including hormonal variations, communication styles, and societal expectations.
- Apply validated pain assessment tools and techniques to accurately evaluate pain in women, considering individual factors and potential biases.
- Develop patient-centered pain management plans for women that incorporate evidence-based pharmacological and nonpharmacological approaches, addressing their unique needs and preferences.
- Communicate effectively with women about their pain, actively listening to their concerns, validating their experiences, and empowering them in shared decision making.
- Recognize and address barriers that women may face in accessing appropriate pain care, including stigma, cultural factors, and health care system challenges.
- Apply optimal strategies to manage patients on opioid analgesics, including initiating therapy, titrating, and discontinuing use, with attention to the unique challenges faced by women, particularly women of color.
- Counsel patients on strategies for safe medication storage and disposal in households with children and other vulnerable individuals, addressing specific challenges women may face as caregivers in these settings.
Faculty
Jasmine Carpenter, PharmD, BCPP
Board-certified Psychiatric Pharmacist
Adjunct Faculty
Howard University College of Pharmacy
Washington, DC
Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, FAANP
Adult Nurse Practitioner
Division of Pain Medicine
Stanford Health Care Anesthesia
Redwood City, California
Adaku Ofoegbu, PharmD, PhD
Assistant Professor
Department of Clinical and Administrative Pharmacy Sciences
Howard University College of Pharmacy
Washington, DC
Saloni Sharma, MD
Medical Director
Clinical Assistant Professor of Rehabilitation Medicine
Rothman Orthopaedic Institute
Thomas Jefferson University
Bryn Mawr, Pennsylvania
Craig M. Thomas, MD
Orthopedic Surgeon
Centers for Advanced Orthopedics
Glenn Dale, Maryland
Shawn-Ta Brown, PharmD, RPH
Clinical Oncology Pharmacist/Pharmacy Consultant
Howard University
Washington, DC
Ameet S. Nagpal, MD, MS, MEd, MBA
Division Chief, PM&R, and Professor
Dept. of Orthopaedics and Physical Medicine & Rehabilitation
Medical University of South Carolina
Charleston, South Carolina
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Kaplan Medical Education, the American Academy of Physical Medicine and Rehabilitation (AAPM&R), and the Howard University College of Pharmacy. Projects In Knowledge is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 6.00 Interprofessional Continuing Education (IPCE) credit(s) for learning and change
Credit Designation
Physicians
Kaplan Medical Education designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Upon completion of this course, participants will be awarded 6.0 nursing contact hours.
Joint Accreditation Nursing Provider Number: 4008235
DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, or KME endorsement of any commercial product or service.
Disclosures of Conflict of Interest
Jasmine Carpenter, PharmD, BCPP, has no relevant financial relationships to disclose.
Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, FAANP, has been on the speakers bureau of Averitas, Axsome, Pfizer Inc., and Vertex Pharmaceuticals.
Adaku Ofoegbu, PharmD, PhD, has no relevant financial relationships to disclose.
Saloni Sharma, MD, has no relevant financial relationships to disclose.
Craig M. Thomas, MD, has no relevant financial relationships to disclose.
Shawn-Ta Brown, PharmD, RPH, has no relevant financial relationships to disclose.
Ameet S. Nagpal, MD, MS, MEd, MBA, has received grant/research support paid directly to the institution from Averitas Pharmaceuticals, Saol Therapeutics, and SPR Therapeutics.
Itza Rivera, MD, (medical writer), has no relevant financial relationships to disclose.
Emma Arigi, PhD (medical writer), has no relevant financial relationships to disclose.
Claire Boville, MPharm, (medical writer), has no relevant financial relationships to disclose.
Kathryn Boltz, PhD, (medical writer), has no relevant financial relationships to disclose.
Sunali Wadehra (medical writer), has no relevant financial relationships to disclose.
Margaret Wright, BSN, RN (medical writer), has no relevant financial relationships to disclose.
Peer Reviewer has no relevant financial relationships to disclose.
The American Academy of Physical Medicine & Rehabilitation (AAPM&R) content reviewers, David W. Lee, MD, and Ameet S. Nagpal, MD, MS, MEd, MBA, have reported the following relationships: Dr. Lee has been a consultant for Abbott Neuromodulation, Boston Scientific, Johnson & Johnson, and Mainstay Medical. Dr. Nagpal has received research funding, paid directly to his institution, from Averitas Pharmaceuticals, Saol Therapeutics, and SPR Therapeutics.
Kaplan Medical Education staff members have no relevant financial relationships to disclose.
The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Kaplan Medical Education.
*An ineligible company (commercial interest) is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used, on patients.
Instructions for Participation and Credit
There are no fees for participating in and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]